NCT05462873 2026-02-17A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid TumorsNovartisPhase 1 Terminated30 enrolled
NCT04272034 2025-10-16Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsIncyte CorporationPhase 1 Terminated105 enrolled
NCT04000529 2025-09-30Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected MalignanciesNovartisPhase 1 Terminated122 enrolled
NCT03114319 2025-08-28Dose Finding Study of TNO155 in Adult Patients With Advanced Solid TumorsNovartisPhase 1 Terminated227 enrolled
NCT04032704 2025-03-10A Study of Ladiratuzumab Vedotin in Advanced Solid TumorsSeagen Inc.Phase 2 Terminated205 enrolled 54 charts
NCT06034860 2024-11-01Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer TypesMolecular Templates, Inc.Phase 1 Terminated15 enrolled
NCT04144140 2024-03-07Study of Intratumorally Administered Stimulator of Interferon Genes (STING) Agonist E7766 in Participants With Advanced Solid Tumors or Lymphomas - INSTAL-101Eisai Inc.Phase 1 Terminated24 enrolled 29 charts
NCT04244552 2023-12-29A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid MalignanciesAtreca, Inc.Phase 1 Terminated87 enrolled